Dow, S&P gain but Nasdaq dips as healthcare lags
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
Twitter, Inc. (TWTR) PT Raised to $19 at Jefferies Following 3Q Beat
October 27, 2017 9:52 AM EDTJefferies raised its price target on Twitter, Inc. (NYSE: TWTR) to $19.00 (from $16.00) while maintaining a Hold rating following the company's 3Q earnings report. Revenues decreased -4% Y/Y to $590M, compared to the Street's $587M estimate. EBITDA of $207M came in ahead... More
Celgene (CELG) PT Lowered to $125 at Jefferies; Reiterates Buy
October 27, 2017 8:40 AM EDTJefferies lowered its price target on Celgene (NASDAQ: CELG) to $125.00 (from $160.00) while maintaining a Buy rating.
While clearly a disappointment and large market reaction, moving forward the question is what could turn this around. Analyst Michael Yee thinks at $95 (close to $80-85 no pipeline value), it's overdone in bigger picture.
... MoreTwitter, Inc. (TWTR) PT Raised to $20 at Baird on 3Q Report; 'Early Signs of Growth Encouraging'
October 26, 2017 2:46 PM EDTBaird raised its price target on Twitter, Inc. (NYSE: TWTR) to $20.00 (from $17.00) while maintaining a Neutral rating, following the company's third quarter earnings report.
Analyst Colin Sebastian comments, "Bottom line, we are more constructive on shares with improving revenue and profit... More
Amgen (AMGN) PT Lowered to $193 at Morgan Stanley Following 3Q
October 26, 2017 9:25 AM EDTMorgan Stanley lowered its price target on Amgen (NASDAQ: AMGN) to $193.00 (from $196.00) while maintaining a Overweight rating following the company's 3Q release. Total revenues were slightly above ($5.77B vs. $5.74B cons), as were COGS (+$10M) and SG&A (+$20M), with R&D... More
Chipotle Mexican Grill (CMG) PT Lowered to $300 at Baird Following 3Q Miss
October 25, 2017 8:59 AM EDTBaird lowered its price target on Chipotle Mexican Grill (NYSE: CMG) to $300.00 (from $340.00) while maintaining a Neutral rating following the company's 3Q. EPS of $1.33 missed consensus on higher-than-expected food costs, one-time impacts from hurricanes, and some unexpected closing/impairment costs.
Management intends to... More

